Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 27359 | 39.52 |
09:34 ET | 3467 | 39.54 |
09:36 ET | 4260 | 39.69 |
09:38 ET | 1200 | 39.87 |
09:39 ET | 1500 | 39.8 |
09:41 ET | 500 | 39.74 |
09:43 ET | 3977 | 39.83 |
09:45 ET | 2201 | 39.83 |
09:48 ET | 726 | 39.82 |
09:50 ET | 900 | 39.85 |
09:52 ET | 3152 | 39.84 |
09:54 ET | 2982 | 39.81 |
09:56 ET | 3350 | 39.76 |
09:57 ET | 2237 | 39.86 |
09:59 ET | 1400 | 39.85 |
10:01 ET | 5645 | 39.89 |
10:03 ET | 3441 | 39.89 |
10:06 ET | 2632 | 39.81 |
10:08 ET | 5062 | 39.795 |
10:10 ET | 4632 | 39.77 |
10:12 ET | 1872 | 39.83 |
10:14 ET | 2977 | 39.86 |
10:15 ET | 2372 | 39.88 |
10:17 ET | 3332 | 39.93 |
10:19 ET | 5197 | 39.92 |
10:21 ET | 3882 | 39.935 |
10:24 ET | 11058 | 40.01 |
10:26 ET | 5498 | 40.02 |
10:28 ET | 4433 | 40.04 |
10:30 ET | 1600 | 40.07 |
10:32 ET | 9395 | 40.1 |
10:33 ET | 996 | 40.09 |
10:35 ET | 4970 | 40.055 |
10:37 ET | 18370 | 40.08 |
10:39 ET | 5398 | 40.08 |
10:42 ET | 3355 | 40.065 |
10:44 ET | 2423 | 40.02 |
10:46 ET | 41906 | 40.05 |
10:48 ET | 25414 | 40.05 |
10:50 ET | 6000 | 40.1 |
10:51 ET | 4805 | 40.05 |
10:53 ET | 4794 | 40.05 |
10:55 ET | 7002 | 39.98 |
10:57 ET | 7503 | 40 |
11:00 ET | 500 | 39.98 |
11:02 ET | 2557 | 39.97 |
11:04 ET | 3876 | 40.07 |
11:06 ET | 1994 | 40.04 |
11:08 ET | 3751 | 40.0401 |
11:09 ET | 2106 | 40.07 |
11:11 ET | 2504 | 40.13 |
11:13 ET | 1765 | 40.14 |
11:15 ET | 3421 | 40.155 |
11:18 ET | 5022 | 40.165 |
11:20 ET | 1912 | 40.19 |
11:22 ET | 1500 | 40.15 |
11:24 ET | 2832 | 40.18 |
11:26 ET | 1700 | 40.165 |
11:27 ET | 16987 | 40.11 |
11:29 ET | 3007 | 40.08 |
11:31 ET | 2166 | 40.07 |
11:33 ET | 6260 | 40.02 |
11:36 ET | 2055 | 39.95 |
11:38 ET | 6867 | 39.96 |
11:40 ET | 2365 | 39.905 |
11:42 ET | 1460 | 39.91 |
11:44 ET | 1903 | 39.85 |
11:45 ET | 1847 | 39.85 |
11:47 ET | 2970 | 39.845 |
11:49 ET | 2170 | 39.81 |
11:51 ET | 2678 | 39.79 |
11:54 ET | 4285 | 39.8 |
11:56 ET | 3063 | 39.845 |
11:58 ET | 4786 | 39.895 |
12:00 ET | 1889 | 39.92 |
12:02 ET | 4387 | 39.93 |
12:03 ET | 1898 | 39.94 |
12:05 ET | 1780 | 39.9 |
12:07 ET | 2212 | 39.91 |
12:09 ET | 983 | 39.82 |
12:12 ET | 2905 | 39.81 |
12:14 ET | 3886 | 39.8 |
12:16 ET | 3494 | 39.835 |
12:18 ET | 1671 | 39.83 |
12:20 ET | 713 | 39.79 |
12:21 ET | 3215 | 39.71 |
12:23 ET | 2604 | 39.715 |
12:25 ET | 2452 | 39.7 |
12:27 ET | 3667 | 39.69 |
12:30 ET | 2513 | 39.73 |
12:32 ET | 2064 | 39.8 |
12:34 ET | 1100 | 39.725 |
12:36 ET | 1000 | 39.69 |
12:38 ET | 2901 | 39.7 |
12:39 ET | 3253 | 39.71 |
12:41 ET | 1355 | 39.7 |
12:43 ET | 3965 | 39.75 |
12:45 ET | 1121 | 39.77 |
12:48 ET | 1025 | 39.77 |
12:50 ET | 3512 | 39.78 |
12:52 ET | 1039 | 39.71 |
12:54 ET | 1908 | 39.71 |
12:56 ET | 1375 | 39.72 |
12:57 ET | 1000 | 39.705 |
12:59 ET | 2958 | 39.75 |
01:01 ET | 1788 | 39.77 |
01:03 ET | 800 | 39.75 |
01:06 ET | 219 | 39.73 |
01:08 ET | 4715 | 39.69 |
01:10 ET | 2786 | 39.69 |
01:12 ET | 2629 | 39.67 |
01:14 ET | 1622 | 39.655 |
01:15 ET | 1773 | 39.68 |
01:17 ET | 1320 | 39.66 |
01:19 ET | 317 | 39.67 |
01:21 ET | 950 | 39.66 |
01:24 ET | 2797 | 39.66 |
01:26 ET | 1225 | 39.64 |
01:28 ET | 3763 | 39.68 |
01:30 ET | 2276 | 39.75 |
01:32 ET | 1849 | 39.75 |
01:33 ET | 2648 | 39.8 |
01:35 ET | 1115 | 39.82 |
01:37 ET | 1600 | 39.82 |
01:39 ET | 3302 | 39.805 |
01:42 ET | 3248 | 39.8 |
01:44 ET | 11181 | 39.85 |
01:46 ET | 2223 | 39.86 |
01:48 ET | 3500 | 39.83 |
01:50 ET | 1698 | 39.87 |
01:51 ET | 2088 | 39.86 |
01:53 ET | 2500 | 39.88 |
01:55 ET | 3392 | 39.82 |
01:57 ET | 2201 | 39.84 |
02:00 ET | 1634 | 39.83 |
02:02 ET | 7029 | 39.89 |
02:04 ET | 2308 | 39.86 |
02:06 ET | 3184 | 39.88 |
02:08 ET | 6504 | 39.75 |
02:09 ET | 3452 | 39.83 |
02:11 ET | 12828 | 39.925 |
02:13 ET | 9020 | 39.96 |
02:15 ET | 2655 | 39.99 |
02:18 ET | 6092 | 40.055 |
02:20 ET | 4349 | 40.015 |
02:22 ET | 3908 | 40.09 |
02:24 ET | 6902 | 40.11 |
02:26 ET | 5304 | 40.12 |
02:27 ET | 4929 | 40.16 |
02:29 ET | 3835 | 40.15 |
02:31 ET | 1383 | 40.2 |
02:33 ET | 3300 | 40.18 |
02:36 ET | 4170 | 40.23 |
02:38 ET | 3106 | 40.2 |
02:40 ET | 1600 | 40.12 |
02:42 ET | 4936 | 40.15 |
02:44 ET | 1902 | 40.15 |
02:45 ET | 1593 | 40.11 |
02:47 ET | 562 | 40.09 |
02:49 ET | 1700 | 40.03 |
02:51 ET | 4495 | 40.07 |
02:54 ET | 2709 | 40.08 |
02:56 ET | 2490 | 40.13 |
02:58 ET | 731 | 40.12 |
03:00 ET | 1800 | 40.13 |
03:02 ET | 2986 | 40.18 |
03:03 ET | 3816 | 40.26 |
03:05 ET | 2108 | 40.26 |
03:07 ET | 3638 | 40.28 |
03:09 ET | 3077 | 40.3 |
03:12 ET | 1483 | 40.3 |
03:14 ET | 3749 | 40.31 |
03:16 ET | 4054 | 40.26 |
03:18 ET | 3981 | 40.26 |
03:20 ET | 3950 | 40.25 |
03:21 ET | 10176 | 40.26 |
03:23 ET | 2605 | 40.195 |
03:25 ET | 4351 | 40.22 |
03:27 ET | 5127 | 40.245 |
03:30 ET | 5996 | 40.23 |
03:32 ET | 6603 | 40.225 |
03:34 ET | 5559 | 40.215 |
03:36 ET | 5781 | 40.21 |
03:38 ET | 4765 | 40.21 |
03:39 ET | 4456 | 40.205 |
03:41 ET | 6196 | 40.175 |
03:43 ET | 11198 | 40.3 |
03:45 ET | 9329 | 40.27 |
03:48 ET | 10451 | 40.29 |
03:50 ET | 10630 | 40.26 |
03:52 ET | 16799 | 40.215 |
03:54 ET | 24455 | 40.265 |
03:56 ET | 25531 | 40.195 |
03:57 ET | 35445 | 40.18 |
03:59 ET | 229960 | 40.21 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 24.1B | 40.3x | --- |
Novo Nordisk A/S | 187.0B | 34.0x | +6.74% |
Horizon Therapeutics PLC | 20.2B | 24.2x | --- |
Incyte Corp | 16.6B | 18.2x | +51.40% |
Catalent Inc | 17.3B | 34.8x | +28.57% |
Jazz Pharmaceuticals PLC | 8.9B | -19.7x | --- |
Royalty Pharma plc is engaged in investing in late stage biopharmaceutical products. The Company invests in academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The Company’s portfolio of pharmaceutical investment includes investments in commercial products and development-stage product candidates. Its portfolio investments include AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko, Trikafta and OXLUMO.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $24.1B |
---|---|
Revenue (TTM) | $2.3B |
Shares Outstanding | 607.2M |
Dividend Yield | 1.89% |
Annual Dividend Rate | 0.7600 USD |
Ex-Dividend Date | 05-19-22 |
Pay Date | 06-15-22 |
Beta | --- |
EPS | $1.00 |
Book Value | $9.51 |
P/E Ratio | 40.3x |
Price/Sales (TTM) | 10.6 |
Price/Cash Flow (TTM) | 19.6x |
Operating Margin | 62.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.